StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Adjusted Operating Income by Quarter

Adjusted Operating Income ($M)

QuarterlyAnnual

Thermo Fisher Scientific Adjusted Operating Income: $2,968M in Q3 2026, up 14.7% from a year earlier.

Latest, Q3 2026
2,968
Period ended Sep 30, 2026
Change on a year earlier
+14.7%
2,587 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
7
Documents cited below

Where the Q3 2026 figure comes from

“Adjusted operating income (non-GAAP measure) 2,269 21.9 % 2,375 21.9 % 2,587 23.3 % 2,878 23.6 % 2,399 21.8 % 2,735 22.8 % 2,968 24.5 %”

Source: Q3 2026 Reconciliation of Financial Information ↗

Reported in IR Financial Reconciliation Package & SEC 8-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAdjusted Operating Income ($M)Year on yearSource
Q3 2026Sep 30, 20262,968+14.7%Q3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20262,735+15.2%Q3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 20262,399+5.7%Q3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20252,878+5.8%Q3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 20252,587+9.5%Q3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 20252,375+1.2%Q3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 20252,269-0.4%Q3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20242,720+6.7%Q4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 20242,362-7.7%Q4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 20242,347-1.0%Q4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 20242,278-2.2%Q4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 20232,550-0.4%Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 20232,560+8.0%Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 20232,370-9.0%Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 20232,330-32.5%Q4 & FY2024 Reconciliation of Financial Information ↗
Q4 2022Dec 31, 20222,560–SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗

Breakdown

What makes up adjusted Operating Income

Cite this data

StockData. (2026). Thermo Fisher Scientific Adjusted Operating Income ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/adj-op-inc

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.